Q4 2025 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2026-02-17 · accession 0000902664-26-001106
$50.6M
Reported value
5
Positions
2025-12-31
Period end
The Brief · 72 Investment Holdings, LLC · Q4 2025
AI · grounded in 13F
72 Investment Holdings, LLC reported no changes to its 13F holdings for 2025-12-31 relative to 2025-09-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $19.4M | 38.4% | 65,933 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $16.3M | 32.2% | 1,017,751 | Common | SHARED |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $11.9M | 23.5% | 667,778 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $2.2M | 4.38% | 276,831 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $753,767 | 1.49% | 474,067 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.